» Articles » PMID: 26319518

Denmark's Policy on Artificial Trans Fat and Cardiovascular Disease

Overview
Journal Am J Prev Med
Specialty Public Health
Date 2015 Aug 31
PMID 26319518
Citations 52
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: The consumption of trans fat is associated with cardiovascular disease (CVD). In January 2004, Denmark became the first country in the world to regulate the content of artificial trans fat in certain ingredients in food products, which nearly eliminated artificial trans fat from the Danish food supply. The goal of this study was to assess whether Denmark's trans fat policy reduced deaths caused by CVD.

Methods: Annual mortality rates in Organisation for Economic Co-operation and Development (OECD) countries from 1990 to 2012 were used to estimate the effect of Denmark's food policy on CVD mortality rates. Synthetic control methods were employed to simulate the CVD mortality trajectory that Denmark would have witnessed in the absence of the policy and to measure the policy's impact on CVD mortality rates. Analyses were conducted in 2015.

Results: Before the trans fat policy was implemented, CVD mortality rates in Denmark closely tracked those of a weighted average of other OECD countries (i.e., the synthetic control group). In the years before the policy, the annual mean was 441.5 deaths per 100,000 people in Denmark and 442.7 in the synthetic control group. In the 3 years after the policy was implemented, mortality attributable to CVD decreased on average by about 14.2 deaths per 100,000 people per year in Denmark relative to the synthetic control group.

Conclusions: Denmark's food policy, which restricted the content of artificial trans fat in certain ingredients in its food supply, has been followed by a decrease in CVD mortality rates.

Citing Articles

Blood biomarkers of trans-fatty acid intake among Nigerian adults in the Federal Capital Territory: a cross-sectional study.

Marklund M, Billyrose S, Orji I, Ikechukwu-Orji M, Okoro C, Obagha C Am J Clin Nutr. 2024; 121(1):125-133.

PMID: 39490795 PMC: 11747188. DOI: 10.1016/j.ajcnut.2024.10.019.


Ending Trans Fat-The First-Ever Global Elimination Program for a Noncommunicable Disease Risk Factor: JACC International.

Steele L, Drummond E, Nishida C, Yamamoto R, Branca F, Parsons Perez C J Am Coll Cardiol. 2024; 84(7):663-674.

PMID: 39111974 PMC: 11320890. DOI: 10.1016/j.jacc.2024.04.067.


The hidden cost of sophistication: economic complexity and obesity.

Djeunankan R, Tadadjeu S, Njangang H, Mazhar U Eur J Health Econ. 2024; 26(2):243-265.

PMID: 38861053 DOI: 10.1007/s10198-024-01699-7.


Social, clinical, and policy implications of ultra-processed food addiction.

Gearhardt A, Bueno N, DiFeliceantonio A, Roberto C, Jimenez-Murcia S, Fernandez-Aranda F BMJ. 2023; 383:e075354.

PMID: 37813420 PMC: 10561019. DOI: 10.1136/bmj-2023-075354.


Impact of Combined Thermal Pressure Treatments on Physical Properties and Stability of Whey Protein Gel Emulsions.

Alinovi M, Rinaldi M, Paciulli M, Bot F, Barbanti D, Chiavaro E Foods. 2023; 12(13).

PMID: 37444185 PMC: 10341143. DOI: 10.3390/foods12132447.